The potential prognostic importance of TG2 in cancer was first recognized with sequential studies on tumor tissues and cell lines of breast cancer, showing elevated levels of TG2 in correlation with drug resistance [31,108]. This evidence concerns the gene TGM2 and breast carcinoma.